PYC Therapeutics Ltd Capital Reinvestment Ratio

Latest as of June 2017: 0.00x

PYC Therapeutics Ltd capital reinvestment ratio. PYC Therapeutics Ltd (PYC) has a Capital Reinvestment Ratio of 0.00x as of June 2017, meaning it reinvests 0% of its operating cash flow (AU$1.73 Million) in capital expenditures (AU$608.00). See PYC Therapeutics Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

AU$1.73 Million
AUD

Capital Expenditures

AU$608.00
AUD

Data as of

Jun 2017
Most recent filing

Capital Reinvestment Ratio of PYC Therapeutics Ltd (2004–2004)

Capital reinvestment ratio of PYC Therapeutics Ltd from 2004 to 2004. This chart tracks PYC Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. See PYC Therapeutics Ltd (PYC) flexibility index to measure the company's free cash flow as a share of total liabilities.

PYC Therapeutics Ltd Capital Reinvestment Ratio by Year (2004–2004)

PYC Therapeutics Ltd capital reinvestment ratio by year from 2004 to 2004. For the full cash flow conversion analysis, see PYC cash flow conversion.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2004 0.11x AU$28.00K AU$3.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow